
The Orange Biomed co-founder has spent five years translating single-cell science into something ordinary people might actually use - and learning that the hardest part of a tiny device is the enormous system around it.
A Duke-born startup turned the stiffness of red blood cells into a pocket-size diabetes test. The science is clever; the harder experiment is getting a regulated device from a five-minute demo into millions of homes.